3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium

C96H133N7O18S2+4 — CID 162073608

IUPAC3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium
SMILESCOCCN1C(=CC=C2CCCC(C=CC3=[N+](CCOC)c4ccc(S(=O)(=O)O)cc4C3(C)C)=C2OCCC[N+](C)(C)CCCC(=O)O)C(C)(C)c2cc(C)ccc21.COCCN1C(=CC=C2CCCC(C=CC3=[N+](CCOC)c4ccc(S(=O)(=O)O)cc4C3(C)C)=C2OCCC[N+](C)(C)CCCC(=O)ON2C(=O)CCC2=O)C(C)(C)c2cc(C)ccc21
InChIInChI=1S/C50H67N4O10S.C46H63N3O8S/c1-35-16-20-41-39(33-35)49(2,3)43(51(41)26-31-61-8)22-17-36-13-10-14-37(18-23-44-50(4,5)40-34-38(65(58,59)60)19-21-42(40)52(44)27-32-62-9)48(36)63-30-12-29-54(6,7)28-11-15-47(57)64-53-45(55)24-25-46(53)56;1-33-16-20-39-37(31-33)45(2,3)41(47(39)24-29-55-8)22-17-34-13-10-14-35(44(34)57-28-12-27-49(6,7)26-11-15-43(50)51)18-23-42-46(4,5)38-32-36(58(52,53)54)19-21-40(38)48(42)25-30-56-9/h16-23,33-34H,10-15,24-32H2,1-9H3;16-23,31-32H,10-15,24-30H2,1-9H3/q+1;/p+3
InChIKeyQZBSVGDZGNEADY-UHFFFAOYSA-Q
MW1737.28 g/mol
LogP15.24
Rot. Bonds39

About 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium

3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium (PubChem CID 162073608) has the molecular formula C96H133N7O18S2+4 and a molecular weight of 1737.28 g/mol. Its IUPAC name is 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium.

Molecular Properties

Compound Name3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium
PubChem CID162073608
Molecular FormulaC96H133N7O18S2+4
Molecular Weight1737.28 g/mol
Exact Mass1735.91
IUPAC Name3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium
SMILESCOCCN1C(=CC=C2CCCC(C=CC3=[N+](CCOC)c4ccc(S(=O)(=O)O)cc4C3(C)C)=C2OCCC[N+](C)(C)CCCC(=O)O)C(C)(C)c2cc(C)ccc21.COCCN1C(=CC=C2CCCC(C=CC3=[N+](CCOC)c4ccc(S(=O)(=O)O)cc4C3(C)C)=C2OCCC[N+](C)(C)CCCC(=O)ON2C(=O)CCC2=O)C(C)(C)c2cc(C)ccc21
InChIInChI=1S/C50H67N4O10S.C46H63N3O8S/c1-35-16-20-41-39(33-35)49(2,3)43(51(41)26-31-61-8)22-17-36-13-10-14-37(18-23-44-50(4,5)40-34-38(65(58,59)60)19-21-42(40)52(44)27-32-62-9)48(36)63-30-12-29-54(6,7)28-11-15-47(57)64-53-45(55)24-25-46(53)56;1-33-16-20-39-37(31-33)45(2,3)41(47(39)24-29-55-8)22-17-34-13-10-14-35(44(34)57-28-12-27-49(6,7)26-11-15-43(50)51)18-23-42-46(4,5)38-32-36(58(52,53)54)19-21-40(38)48(42)25-30-56-9/h16-23,33-34H,10-15,24-32H2,1-9H3;16-23,31-32H,10-15,24-30H2,1-9H3/q+1;/p+3
InChIKeyQZBSVGDZGNEADY-UHFFFAOYSA-Q
XLogP15.24
TPSA277.60 Ų
H-Bond Donors3
H-Bond Acceptors17
Rotatable Bonds39
Heavy Atoms123
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001737.28
LogP ≤ 515.24
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Analyze 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium?
The IUPAC name of 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium (CID 162073608) is 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium.
What is the SMILES notation for 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium?
The canonical SMILES for 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium is COCCN1C(=CC=C2CCCC(C=CC3=[N+](CCOC)c4ccc(S(=O)(=O)O)cc4C3(C)C)=C2OCCC[N+](C)(C)CCCC(=O)O)C(C)(C)c2cc(C)ccc21.COCCN1C(=CC=C2CCCC(C=CC3=[N+](CCOC)c4ccc(S(=O)(=O)O)cc4C3(C)C)=C2OCCC[N+](C)(C)CCCC(=O)ON2C(=O)CCC2=O)C(C)(C)c2cc(C)ccc21.
What is the InChIKey of 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium?
The InChIKey is QZBSVGDZGNEADY-UHFFFAOYSA-Q. The full InChI is InChI=1S/C50H67N4O10S.C46H63N3O8S/c1-35-16-20-41-39(33-35)49(2,3)43(51(41)26-31-61-8)22-17-36-13-10-14-37(18-23-44-50(4,5)40-34-38(65(58,59)60)19-21-42(40)52(44)27-32-62-9)48(36)63-30-12-29-54(6,7)28-11-15-47(57)64-53-45(55)24-25-46(53)56;1-33-16-20-39-37(31-33)45(2,3)41(47(39)24-29-55-8)22-17-34-13-10-14-35(44(34)57-28-12-27-49(6,7)26-11-15-43(50)51)18-23-42-46(4,5)38-32-36(58(52,53)54)19-21-40(38)48(42)25-30-56-9/h16-23,33-34H,10-15,24-32H2,1-9H3;16-23,31-32H,10-15,24-30H2,1-9H3/q+1;/p+3.
What are the key properties of 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium?
3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium has a molecular weight of 1737.28 g/mol, XLogP of 15.24, 39 rotatable bonds, 3 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 3-carboxypropyl-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium;[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutyl]-[3-[2-[2-[1-(2-methoxyethyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-6-[2-[1-(2-methoxyethyl)-3,3,5-trimethylindol-2-ylidene]ethylidene]cyclohexen-1-yl]oxypropyl]-dimethylazanium is sourced from PubChem (CID 162073608), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).